Cargando…
Pharmacokinetics, safety and efficacy from randomized controlled trials of 1 and 2 mg nicotine bitartrate lozenges (Nicotinell(®))
BACKGROUND: The use of nicotine replacement therapy (NRT) can almost double the chances of success for smokers to quit. Nevertheless, there is still a considerable number of cessation attempts that are made without any treatment. This novel oral formulation, (lozenge containing nicotine bitartrate d...
Autores principales: | Dautzenberg, Bertrand, Nides, Mitchell, Kienzler, Jean-Luc, Callens, Anne |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2007
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2194660/ https://www.ncbi.nlm.nih.gov/pubmed/17922899 http://dx.doi.org/10.1186/1472-6904-7-11 |
Ejemplares similares
-
Pharmacokinetic characterization of three novel 4-mg nicotine lozenges
por: Sukhija, Manpreet, et al.
Publicado: (2018) -
A Multicenter, Randomized, Double-blind, Parallel, Placebo-controlled Clinical Study to Evaluate the Efficacy and Safety of a Nicotine Mint Lozenge (2 and 4 mg) in Smoking Cessation
por: Xiao, Dan, et al.
Publicado: (2020) -
Nicotine Bitartrate Reduces Falls and Freezing of Gait in Parkinson Disease: A Reanalysis
por: Lieberman, Abraham, et al.
Publicado: (2019) -
Single‐Dose Bioequivalence of Two Mini Nicotine Lozenge Formulations
por: Rasmussen, Scott C., et al.
Publicado: (2017) -
A novel sustained‐release cysteamine bitartrate formulation for the treatment of cystinosis: Pharmacokinetics and safety in healthy male volunteers
por: Berends, Cécile L., et al.
Publicado: (2021)